These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7802694)

  • 1. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of acid secretion following treatment with proton pump inhibitors.
    Shin JM; Sachs G
    Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
    Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
    Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
    Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.
    Besancon M; Simon A; Sachs G; Shin JM
    J Biol Chem; 1997 Sep; 272(36):22438-46. PubMed ID: 9278394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
    Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
    Lew EA; Barbuti RC; Kovacs TO; Sytnic B; Humphries TJ; Walsh JH
    Aliment Pharmacol Ther; 1998 Jul; 12(7):667-72. PubMed ID: 9701531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomeric regulation of gastric H+,K+-ATPase.
    Morii M; Hayata Y; Mizoguchi K; Takeguchi N
    J Biol Chem; 1996 Feb; 271(8):4068-72. PubMed ID: 8626741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
    Morii M; Takeguchi N
    J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M; Hamatani K; Takeguchi N
    Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
    Nagaya H; Inatomi N; Nohara A; Satoh H
    Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New fluorescent probes E3810 and methoxy E3810 for determining distributions of the apical membrane and the acidic compartment of gastric acid secreting cells.
    Takeguchi N; Yamanouchi T; Sakai H; Morii M
    Jpn J Physiol; 1992; 42(1):75-88. PubMed ID: 1320706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Lorentzon P; Bayati A; Lee H; Andersson K
    Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible mechanisms for (H+ + K+)-ATPase inhibition by proton pump inhibitors, omeprazole, lansoprazole and SCH 28080].
    Nagaya H; Satoh H
    Nihon Rinsho; 1992 Jan; 50(1):26-32. PubMed ID: 1311786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y
    J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.